[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU7568794A - Hiv (vif)-related compositions, and prophylactic and therapeutic uses thereof - Google Patents

Hiv (vif)-related compositions, and prophylactic and therapeutic uses thereof

Info

Publication number
AU7568794A
AU7568794A AU75687/94A AU7568794A AU7568794A AU 7568794 A AU7568794 A AU 7568794A AU 75687/94 A AU75687/94 A AU 75687/94A AU 7568794 A AU7568794 A AU 7568794A AU 7568794 A AU7568794 A AU 7568794A
Authority
AU
Australia
Prior art keywords
vif
hiv
prophylactic
therapeutic uses
related compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU75687/94A
Inventor
Mary Jane Potash
David J Volsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
St Lukes Roosevelt Hospital Center
Original Assignee
ST LUKE S ROOSEVELT HOSPITAL C
St Lukes Roosevelt Hospital Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ST LUKE S ROOSEVELT HOSPITAL C, St Lukes Roosevelt Hospital Center filed Critical ST LUKE S ROOSEVELT HOSPITAL C
Publication of AU7568794A publication Critical patent/AU7568794A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU75687/94A 1993-08-20 1994-08-19 Hiv (vif)-related compositions, and prophylactic and therapeutic uses thereof Abandoned AU7568794A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11022693A 1993-08-20 1993-08-20
US110226 1993-08-20
PCT/US1994/009313 WO1995005851A1 (en) 1993-08-20 1994-08-19 HIV vif-RELATED COMPOSITIONS, AND PROPHYLACTIC AND THERAPEUTIC USES THEREOF

Publications (1)

Publication Number Publication Date
AU7568794A true AU7568794A (en) 1995-03-21

Family

ID=22331893

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75687/94A Abandoned AU7568794A (en) 1993-08-20 1994-08-19 Hiv (vif)-related compositions, and prophylactic and therapeutic uses thereof

Country Status (2)

Country Link
AU (1) AU7568794A (en)
WO (1) WO1995005851A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6776986B1 (en) 1996-06-06 2004-08-17 Novartis Ag Inhibition of HIV-1 replication by antisense RNA expression
CA2304125A1 (en) * 1997-09-18 1999-03-25 Velpandi Ayyavoo Attenuated vif dna immunization cassettes for genetic vaccines
CN1339320A (en) * 2000-08-18 2002-03-13 清华大学 AIDS vacuum and its preparing method and use
CA2442909C (en) 2001-04-06 2011-11-29 Thomas Jefferson University Multimerization of hiv-1 vif protein as a therapeutic target
WO2005024422A2 (en) 2003-05-23 2005-03-17 Oregon Health & Science University Methods for identifying inhibitors
US20050222068A1 (en) 2003-10-23 2005-10-06 Mourich Dan V Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells
US8158770B2 (en) 2004-05-06 2012-04-17 University Of Rochester Content dependent inhibitors of cytidine deaminases and uses thereof
CA2746508A1 (en) 2008-12-17 2010-07-15 Avi Biopharma, Inc. Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0454781B1 (en) * 1989-01-23 1998-12-16 Chiron Corporation Recombinant cells for therapies of infection and hyperproliferative disorders and preparation thereof
FR2647809B1 (en) * 1989-06-02 1991-09-20 Pasteur Institut OLIGONUCLEOTIDE PRIMERS FOR THE AMPLIFICATION OF THE GENOME OF HIV-1, HIV-2 AND SIV RETROVIRUSES AND THEIR APPLICATIONS TO IN VITRO DIAGNOSIS OF INFECTIONS DUE TO THESE VIRUSES
JP3428012B2 (en) * 1989-06-02 2003-07-22 インスティチュート・パスツール Nucleotide sequences from the genomes of HIV-1, HIV-2 and SIV type retroviruses, and especially these for amplification of the genomes of these retroviruses and for "in vitro" diagnosis of infection by these viruses Application of array of
GB8923123D0 (en) * 1989-10-13 1989-11-29 Connaught Lab A vaccine for human immunodeficiency virus

Also Published As

Publication number Publication date
WO1995005851A1 (en) 1995-03-02

Similar Documents

Publication Publication Date Title
AU7564694A (en) Erection-inducing methods and compositions
AU7323294A (en) Perfluoroelastomeric compositions and methods
AU7207094A (en) Wrist brace
AU7138394A (en) N,n-diacylpiperazines
AU5494294A (en) Hop extract and use thereof
AU8074694A (en) Keyboard
AU1248395A (en) Bandages
AU5794094A (en) Tricritical point composition
AU9075591A (en) N-halochitosans, their preparation and uses
AU5505794A (en) Alkali-treated bagasse, and its preparation and uses
AU6782694A (en) Screenless hammermill
AU7796494A (en) Compositions including two hydrofluorocarbons
AU7957794A (en) Anti-allergic, anti-inflammatory compounds, compositions and uses
AU7320894A (en) Red powder articles, compositions and methods
NZ250863A (en) Pseudopeptides, preparation and antiviral compositions
AU5798996A (en) Adnaz, compositions and processes
AU7568794A (en) Hiv (vif)-related compositions, and prophylactic and therapeutic uses thereof
AU5922694A (en) 2-amino-4-quinolyl-dihydropyridines, processes for their preparation, and their use
AU1441195A (en) Phenylmethyl hexanamides, and the use thereof
AU7741394A (en) High tear strength silicone compositions
AU5773994A (en) Cable-making compositions
AU6242494A (en) Slip resistant compositions and uses
AU6511294A (en) Tonometer
AU3286993A (en) Explosive composition, manufacture and use thereof
AU1119895A (en) External preparation